Haemonetics Scientific Advisory Council

The Haemonetics Scientific Advisory Council reflects our continued commitment to science, clinical excellence and our innovation agenda. The council is comprised of industry leaders from around the globe and across multiple clinical areas.

Objectives for the Scientific Advisory Council include:

Scientific Advisory Council Members

• 

• BRYAN A. COTTON, MD, MPH

  Professor, Department of Surgery, University of Texas Health Science Center 
  

  Dr. Bryan Cotton’s clinical specialties are trauma surgery and surgical critical care. His research focuses on identifying best resuscitation strategies for hemorrhagic shock, the early prediction of patients who will receive massive transfusion of blood and blood products, and use of thrombelastography to guide resuscitation and correct coagulopathy following injury. 

  Recently, he has investigated how best to manage severe bleeding in patients taking newer oral anticoagulants. Dr. Cotton holds funding from the National Institutes of Health, the State of Texas Emerging Technologies Fund and the Department of Defense. 

  Dr. Cotton is on faculty at the Center for Translational Injury Research in Houston and is the Director of the Surgical Critical Care, Trauma Surgery and Acute Care Surgery Fellowships at UT-Houston. He is a member of numerous societies, including the American Association for the Surgery of Trauma, the Society of University Surgeons and the Southern Surgical Association. He is also a Fellow of the American College of Surgeons and the Royal College of Surgeons and Physicians-Glasgow. 

  More
• 

• MELISSA CUSHING, MD

  Professor of Pathology and Laboratory Medicine and Professor of Anesthesiology at Weill Cornell Medicine  
  

  Dr. Melissa Cushing is a Professor of Pathology and Laboratory Medicine and a Professor of Anesthesiology at Weill Cornell Medicine in New York City. She is Vice Chair of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine and the Director of the Clinical Laboratories and the Director of Transfusion Medicine and Cellular Therapy at NewYork-Presbyterian Hospital, Weill Cornell Campus.  

  She attended Duke University in Durham, North Carolina, Georgetown University School of Medicine in Washington, D.C., Emory University School of Medicine in Atlanta, Georgia, for Clinical Pathology Residency Training, and John Hopkins School of Medicine in Baltimore, Maryland, for her Transfusion Medicine Fellowship. She has published over 120 original research articles, editorials, book chapters and reviews. Her areas of expertise include the treatment of perioperative bleeding, patient blood management, laboratory stewardship, viscoelastic testing and innovation in the clinical laboratories. She is an Associate Editor of Transfusion and on the Editorial Board of British Journal of Anesthesiology. She is the Chair of the Selection of Abstract Committee for the AABB Annual Meeting. She gives lectures at national and international meetings on the targeted treatment of bleeding and patient blood management. Most recently, she has overseen the implementation of multiple diagnostic and serology SARS-Cov-2 assays at the NewYork-Presbyterian Hospital, Weill Cornell Campus, during the COVID-19 pandemic in New York City.  

  More
• 

• STEVEN FRANK, MD

  Professor, Johns Hopkins University School of Medicine

  Dr. Steven Frank has more than 30 years of experience as an anesthesiologist. His recent work relates to clinical studies in the area of blood utilization, with a special focus on the collection and analysis of transfusion data from electronic medical records and methods for using such data to improve practice. He is involved in ongoing studies to determine mechanisms of the red blood cell storage lesion.

  Dr. Frank is the Director of the Blood Management Program at the Johns Hopkins Hospital and is also the Medical Director of the Center for Bloodless Medicine and Surgery at Johns Hopkins. He has published more than 120 peer-reviewed articles, and over 20 reviews and book chapters. He is currently on the editorial board of the journal Transfusion, and he has been a reviewer for 20 different peer-reviewed journals. He has served on the Board of Directors for the Society for Advancement of Blood Management (SABM) and as Director of SABM’s research committee. Dr. Frank is currently serving his second term on the AABB Board of Directors.

  More
• 

• JAMES GROTTA, MD

  Vascular Neurologist, Memorial Hermann Medical Group
  Director of Stroke Research, Clinical Institute for Research and Innovation, Memorial Hermann-Texas Medical Center

  Dr. James Grotta has devoted his career to translational research in discovering, testing and applying new therapies for acute stroke. He has been funded by the National Institutes of Health (NIH) and the American Stroke Association for laboratory studies on the biology of brain injury and recovery in animal stroke models. He has played a leadership role in many clinical research studies of both thrombolytic drugs and cytoprotective agents after stroke.

  Dr. Grotta has orchestrated a collaborative network of regional stroke centers to increase the delivery of appropriate therapy to a large number of acute stroke patients in Houston. He has extended these efforts to rural areas through regional educational programs and, more recently, telemedicine.

  In 2013, he moved his practice to Memorial Hermann Hospital to lead the Mobile Stroke Unit Consortium, raising money and coordinating efforts to successfully deploy the nation's first Mobile Stroke Unit. He has been an editor of Annals of Neurology, Stroke, Neurology Today and many other peer-reviewed journals, and he has been a member of several NIH and FDA review panels. He has authored or co-authored more than 350 articles in peer-reviewed journals.

  Dr. Grotta received his education at Dartmouth College and his medical training at the Universities of Virginia and Colorado, and at Massachusetts General Hospital before joining the faculty at UT-Houston in 1979. He also spent two years in the U.S. Public Health Service (Indian Health Service).

  More
• 

• JEFFREY McCULLOUGH, MD

  Professor Emeritus of Laboratory Medicine and Pathology, University of Minnesota

  Dr. Jeffrey McCullough is an international leader in transfusion medicine research and practice and in clinical trials involving transfusions for treating diseases of the blood, bone marrow and bleeding conditions. In recent years he has focused his research on clinical trials involving transfusion medicine, and blood donation and blood banking practices in developing countries.

  Dr. McCullough has been Director of Blood Bank for 35 years, and he was a leader in blood bank support for solid organ and stem cell transplant patients. He established a major apheresis program as well as a leading stem cell processing laboratory in the U.S. He has been Director of Clinical Laboratories for about six years. He is founding President of the National Marrow Donor Program, which now has about 10 million donors and has facilitated about 60,000 transplants worldwide.

  Dr. McCullough has been Director and CEO of the American Red Cross Regional Blood Center in St. Paul for 20 years as well as Senior Vice President for Biomedical Affairs at ARC National Headquarters in Washington, DC, with responsibility for half the U.S. blood supply.

  He has been the recipient of Federal research grants (NIH, CDC) for many years and has published more than 300 research reports and an own book, Transfusion Medicine, currently in fourth edition. He has been an editor of Transfusion for 15 years.  

  More
• 

• MICHAEL F. MURPHY, MD

  Professor of Transfusion Medicine, University of Oxford
  Consultant Hematologist, NHS Blood and Transplant (NHSBT) and Oxford University Hospitals

  Dr. Michael Murphy qualified at St. Bartholomew’s Hospital Medical College, University of London, where he completed his training in hematology and became a Senior Lecturer in hematology. He is a recipient of the British Blood Transfusion Society's Kenneth Goldsmith Award. He also co-founded the NHSBT Clinical Studies Unit, its Systematic Reviews Initiative for Transfusion Medicine and the Transfusion Evidence Library.

  His work using technology to improve transfusion practice has won numerous national awards and is an exemplar for the NHS Quality, Innovation, Productivity and Prevention (QIPP) initiative. Dr. Murphy chaired the National Institute for Health and Care Excellence (NICE) guideline on transfusion published in November 2015. He is current Chair of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and Vice President of the American Association of Blood Banks.

  More
• 

• PAUL N. NESS, MD

  Director of the Transfusion Medicine Division, The Johns Hopkins Hospital
  Professor of Pathology, Medicine and Oncology, The Johns Hopkins University School of Medicine

  Dr. Ness received his undergraduate education at the Massachusetts Institute of Technology and his medical degree from the State University of New York at Buffalo. His postgraduate work includes a residency in internal medicine at Johns Hopkins, fellowship training in hematology-oncology at the University of California San Francisco, and a transfusion medicine fellowship at Irwin Memorial Blood Bank in San Francisco.

  From 1972-1974, Dr. Ness was a staff associate in the Division of Blood Diseases and Resources of the National Heart, Lung, and Blood Institute at the National Institutes of Health in Bethesda, Maryland. He has been a member of the American Association of Blood Banks (AABB) Board of Directors for many years and became President in 1999. He served on the editorial boards of Transfusion and AABB Press and became editor of Transfusion in July, 2003. Dr. Ness has written over 200 articles for medical journals and has reviewed manuscripts for many journals. He is a co-editor of two comprehensive texts in transfusion medicine, "Scientific Basis of Transfusion Medicine" and "Blood Banking and Transfusion Medicine, Basic Principles and Practice."

  Dr. Ness also has extensive experience in transfusion-related research with emphasis on transfusion-related complications. He served as a PI for the Johns Hopkins site of the Transfusion Medicine Hemostasis Clinical Trial Network, funded by NHLBI. Dr. Ness is the co-PI for a project funded by the NHLBI REDS III program to study donor virus epidemiology and blood utilization issues in China.

  More
• 

• MARCO RANUCCI, MD

  Director, Cardiothoracic and Vascular Anesthesia and ICU Department, IRCCS Policlinico San Donato Hospital, Milan

  Dr. Marco Ranucci’s clinical interests include risk stratification in cardiac surgery. In this area, he is the inventor of the age, creatinine and ejection fraction (ACEF) score, a risk score for cardiac surgery and percutaneous coronary intervention (PCI) included in the European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines. He is also interested in cardiopulmonary bypass technologies as well as hemostasis and coagulation in critically ill patients. 

  Dr. Marco Ranucci is the author of 217 peer-reviewed publications. He participated in writing the hemostasis and coagulation guidelines of the EACTA/EACTS and those of the Society of Cardiovascular Anesthesiologists. He is in charge of writing the anticoagulation guidelines during extracorporeal membrane oxygenation (ECMO) of the Extracorporeal Life Support Organization. He is also past President of Italian Association of Cardiothoracic Anesthesiologists (ITACTA) and European Association of Cardiothoracic Anesthesiologists (EACTA). Dr. Ranucci has authored three books in the areas of transesophageal echo (Cambridge University Press), cardiac anesthesia (Oxford University Press) and hemostasis/coagulation (Springer Verlag).

  More
• 

• MARTIN SCHREIBER, MD

  Chief of Trauma, Critical Care and Acute Care Surgery, Oregon Health & Science University (OHSU)

  Dr. Martin Schreiber’s special areas of interest are trauma surgery and surgical critical care. He directs the Trauma Laboratory at OHSU. His research interests include resuscitation of hemorrhagic shock, hemorrhage control and development of novel blood products. Current funding sources include the National Institutes of Health, U.S. Army, U.S. Air Force and private industry. His lab is engaged in over 40 investigational protocols at OHSU. He is a leader in the trauma community and has been an invited speaker throughout the U.S. and around the world.

  Dr. Martin Schreiber is the Chief of Region 10 of the American College of Surgeons (ACS) Regional Committees on Trauma, and as such he supervises the ACS Committees in Alaska, Washington, Oregon and Idaho. He is a Colonel in the U.S. Army Reserve and has been deployed three times to Iraq and Afghanistan, and has served as the U.S. Army Joint Theater Trauma System Director.

  Dr. Schreiber completed medical school at Case Western Reserve University, and completed a residency and fellowship at the University of Washington.

  More
• 

• EDWARD L. SNYDER, MD

  Transfusion Service and Therapeutic Apheresis Director, Yale University/Yale New Haven Hospital

  Dr. Edward Snyder is an internationally known Transfusion Medicine expert, who has served on over 130 National Institutes of Health Study Section, Committee and SEP positions, many as Chair. Dr. Snyder has been a consultant and reviewer for the FDA. He is a past Board Chair of the National Marrow Donor Program and a past President of the American Association of Blood Banks. He was Chair of the American Society of Hematology Subcommittee on Transfusion Medicine for several terms and is currently an associate editor of the journal Transfusion. 

  Dr. Snyder is currently Primary Investigator (PI) on the Yale-National Heart, Lung and Blood Institute (NHLBI), REDS-III contract. This contract REDS-III (Recipient Epidemiology and Donor Evaluation Study – III) is designed to evaluate the use of blood and blood products in patients and to determine the incidence of adverse events in blood transfusion recipients. He is also studying the role of pathogen reduction on the blood supply and is Yale site PI on an FDA-required Phase IV evaluation of a recently approved pathogen reduction technology using UV-A and psoralen to inactivate blood borne pathogens. Dr. Snyder also runs the Apheresis Core Laboratory at Yale, which provides human white cells to researchers at the medical center.

  Dr. Snyder receives extramural funding from the NHLBI as PI of the REDS-III contract, as well as extramural funding from industry as regards the Pathogen Reduction observational study alluded to above. He has received several R13 grants from NHLBI to conduct cutting-edge conferences on topics in Transfusion. He has published and presented over 350 publications, book chapters and abstracts.

  Dr. Snyder received his medical degree from New York Medical College.

  More
• 

• DONAT R. SPAHN, MD

  Professor and Chairman, Institute of Anesthesiology, University Hospital Zurich

  Dr. Donat Spahn received his medical degree from the University of Zurich, Switzerland. This was followed by several clinical and research posts within Switzerland and the U.S. He spent three years as a Research Associate in the Department of Anesthesiology at Duke University Medical Center, Durham, NC. He previously spent six years as Professor and Chairman of the Department of Anesthesiology at the University and University Hospital of Lausanne, Switzerland.

  Dr. Spahn’s primary research areas include concepts to minimize the use of perioperative blood products and the management of massive bleeding. He is one of the founders of patient blood management. He has published more than 300 scientific articles, 13 books and over 40 chapters. These publications include numerous original papers and review articles on the transfusion of blood products, including the European guidelines for the management of bleeding following major trauma. He served on the editorial board for various anesthesia journals, and has participated in numerous committees and scientific advisory boards.

  More
• 

• OKSANA VOLOD, MD

  Associate Professor of Pathology, Cedars-Sinai Medical Center
  Director, Coagulation, Cedars-Sinai Medical Center

  Dr. Oksana Volod is a pathologist in West Hollywood, California, and is affiliated with Cedars-Sinai Medical Center. She has been in practice for more than 20 years, and she specializes in coagulation and hematopathology. Her clinical and research interests include thromboelastograph (TEG) utilization for diagnosis and personalized treatment of complex coagulopathies, development of optimal anticoagulation for patients on mechanical circulatory support devices, analysis of the effect of high body mass index on hemostasis in various clinical settings, and defining early trauma induced coagulopathy using TEG.

  Dr. Volod is member of the Coagulation Resource Committee with the College of American Pathologists and on the Board of Directors for the California Association to Aid Ukraine. She is also Chairman and Organizer of Coagulation Educational Symposium at Cedars-Sinai Medical Center.

  She received her medical degree from the Faculty of Medicine at Uzhhorod National University.

  More
• 

• JONATHAN WATERS, MD

  Professor, Departments of Anesthesiology and Bioengineering, University of Pittsburgh
  Chief, Division of Anesthesiology, Magee-Womens Hospital of the University of Pittsburgh Medical Center (UPMC)

  Dr. Jonathan Waters’ areas of expertise primarily focus on transfusion management, blood salvage and obstetrics. He has been federally funded to support investigation in these areas with over 100 peer-reviewed publications and four books on the topic of blood management as well as a book on neurologic disease in pregnancy. In addition to conducting research, he has served on the editorial board of the journal Transfusion and is currently serving as an associate editor.

  Dr. Waters is Vice Chair for Clinical Research in the Department of Anesthesiology, Medical Director for the Acute and Interventional Pain Program at UPMC, Program Director of the Acute Pain and Regional Anesthesiology fellowship, as well as a member of the McGowan Institute for Regenerative Medicine. He is also Medical Director of the Patient Blood Management Program at UPMC and Medical Director of the Blood Management Division for Procirca, Inc., which is a UPMC-owned Biomedical Engineering Company.

  Dr. Waters is a past President of the Society for the Advancement of Blood Management. He served on the Board of Directors of the American Association of Blood Banks between 2011 and 2015. He co-chaired the blood management technical advisory panel for the Joint Commission from 2007 to 2011, which developed performance measures related to blood management. He now serves as Chair of a technical advisory panel to make these measures electronic continuous quality measures.

  More
• 

• MARLENE S. WILLIAMS, MD, FACC
  

  CICU Director, Johns Hopkins Bayview Medical Center
  Associate Professor of Medicine, Johns Hopkins University School of Medicine
  

  Dr. Marlene Williams is currently the director of the Cardiac Intensive Care Unit at Johns Hopkins Bayview Medical Center where she runs a platelet physiology laboratory. Dr. Williams’ research focuses on platelet function as it relates to the acute coronary syndrome. The goal of her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may eventually be translated to therapies for patients with cardiovascular disease.
  
  

  Dr. Williams is a prior recipient of a National Institutes of Health (NIH) Mentored Patient-Oriented Research Career Development Award (K23) for examining platelet functional genomics and an NIH Research Project Grant (R01) award addressing platelet serotonin signaling in depression and heart disease. She has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, heart disease and depression, and has participated in several National Heart, Lung, and Blood Institute advisory committees, review groups and study sections.
  
  Dr. Williams received her undergraduate degree in biochemistry from McGill University and earned her medical degree from Columbia University College of Physicians & Surgeons as well as completed a residency at Johns Hopkins Hospital. After completing her residency, she completed her cardiology fellowship at Mount Sinai Hospital and Johns Hopkins Hospital.
  
  
  

  
  

  More
• 

• KAI ZACHAROWSKI, MD, PhD

  Professor and Chairman, Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt

  Dr. Kai Zacharowski holds the position of Ordinarius and has been Director of the Department of Anesthesia, Intensive Care Medicine and Pain Therapy at the University Hospital Frankfurt since 2009. From 2006-2008, he was the Chair of Anesthesia and Intensive Care Medicine at the University Hospital Bristol.

  His research, teaching and consulting interests are in both clinical and basic aspects of patient safety, transfusion and clotting, innate immunity, cardiovascular and critical care medicine. His scientific contributions are published in peer-reviewed journals such as Nature Medicine, Lancet, New England Journal of Medicine and Proceedings of the National Academy of Science. He has received numerous awards for innovative clinical research.

  He serves as Editor-in-Chief for the Journal of Anesthesia & Intensive Care Medicine as well as an editorial board member of numerous journals in critical care medicine, emergency medicine and anesthesia. He is also the CEO of the Lohfert Foundation.

  He received his medical degree from the German University of Mainz and his PhD from Queen Mary University of London.

  More